BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10290109)

  • 1. Documentation of clinical interactions: quality of care issues and economic considerations in critical care pharmacy.
    Bearce WC; Willey GA; Fox RL; Coleman LT
    Hosp Pharm; 1988 Oct; 23(10):883-4, 886, 889-90. PubMed ID: 10290109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Documentation of clinical and cost-saving pharmacy interventions in the emergency room.
    Levy DB
    Hosp Pharm; 1993 Jul; 28(7):624-7, 630-4, 653. PubMed ID: 10127297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four years' experience with a clinical intervention program: cost avoidance and impact of a clinical coordinator.
    Catania HF; Yee WP; Catania PN
    Am J Hosp Pharm; 1990 Dec; 47(12):2701-5. PubMed ID: 2278286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
    Chuang LC; Sutton JD; Henderson GT
    Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomics: therapeutic and economic considerations in treating the critically ill patient.
    Crane VS
    DICP; 1990 Nov; 24(11 Suppl):S24-7. PubMed ID: 2125394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computerized system to improve documentation and reporting of pharmacists' clinical interventions, cost savings, and workload activities.
    Zimmerman CR; Smolarek RT; Stevenson JG
    Pharmacotherapy; 1995; 15(2):220-7. PubMed ID: 7624270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a pharmacy-based cost-containment program on cimetidine costs and use.
    Kong KM; Johnson WF; Anderson PO; Sato LA; Simonian RI
    Am J Hosp Pharm; 1987 Sep; 44(9):2068-73. PubMed ID: 3674045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automation is prescription for revamping pharmacy services at North Carolina hospital.
    Health Care Cost Reengineering Rep; 1998 Apr; 3(4):53-6. PubMed ID: 10178978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient care contributions of clinical pharmacists in four ambulatory care clinics.
    Hatoum HT; Witte KW; Hutchinson RA
    Hosp Pharm; 1992 Mar; 27(3):203-6, 208-9. PubMed ID: 10116720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using clinical interventions to cost-justify additional pharmacy staff.
    Catania HF; Catania PN
    Hosp Pharm; 1988 Jun; 23(6):544, 546-8. PubMed ID: 10312548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic impact of clinical pharmacists' unsolicited recommendations.
    Torok N; Brown G
    Hosp Pharm; 1992 Dec; 27(12):1052-3, 1056-8, 1060. PubMed ID: 10122507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pharmacist interventions on drug therapy costs in a surgical intensive-care unit.
    Miyagawa CI; Rivera JO
    Am J Hosp Pharm; 1986 Dec; 43(12):3008-13. PubMed ID: 3812508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Documentation of the first steps of pediatric pharmaceutical care in a county hospital.
    Lal LS; Anassi EO; McCants E
    Hosp Pharm; 1995 Dec; 30(12):1107-8, 1111-2. PubMed ID: 10153657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Justification and operation of a critical-care satellite pharmacy.
    Caldwell RD; Tuck BA
    Am J Hosp Pharm; 1983 Dec; 40(12):2141-5. PubMed ID: 6660227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving a hospital pharmacy department's profitability.
    Grauer DW
    Am J Hosp Pharm; 1983 Jul; 40(7):1183-7. PubMed ID: 6881157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of DRGs and cost-containment: assessment by hospital pharmacy directors.
    McGhan WF; Larson LN; Raisch DW
    Hosp Formul; 1986 Aug; 21(8):870-1, 874-6. PubMed ID: 10311626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective-pricing strategies for hospital and departmental effectiveness: the pharmacist's response.
    Gouveia WA
    Am J Hosp Pharm; 1985 Oct; 42(10):2164-8. PubMed ID: 3933335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continued cost justification of an operating room satellite pharmacy.
    Fiala D; Grady KP; Smigla R
    Am J Hosp Pharm; 1993 Mar; 50(3):467-9. PubMed ID: 8442463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.